Karen L. Tedesco

Hematology | Oncology | Internal Medicine

400 Patroon Creek Blvd
Ste 1
Albany, NY 12206

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion.

Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion.

Journal: NPJ breast cancer

Published: August 29, 2025

Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients.

Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients.

Journal: NPJ breast cancer

Published: January 14, 2021

Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2-negative Metastatic Breast Cancer.

Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2-negative Metastatic Breast Cancer.

Journal: Clinical breast cancer

Published: June 18, 2019

An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.

An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.

Journal: Cancer medicine

Published: October 20, 2017

Primary Neuroendocrine Carcinoma of the Middle Mediastinum Involving the Right Main Pulmonary Artery.

Primary Neuroendocrine Carcinoma of the Middle Mediastinum Involving the Right Main Pulmonary Artery.

Journal: The Annals of thoracic surgery

Published: April 22, 2015

Showing 1-5 of 5

Last Updated: 09/26/2026